Chiang, C. L. et al. Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: A systematic review of the literature. Front. Oncol. 11, (2021).
Torre, L. A. et al. Global cancer statistics, 2012: Global Cancer Statistics, 2012. CA Cancer J. Clin. 65, 87–108 (2015).
Google Scholar
Wei, K., Xu, Y., Liu, J., Zhang, W. & Liang, Z. Histopathological classification of nasopharyngeal carcinoma. Asian Pac. J. Cancer Prev. 12, 1141–1147 (2011).
Google Scholar
El-Naggar, A. K., Chan, J. K. C., Takata, T., Grandis, J. R. & Slootweg, P. J. The fourth edition of the head and neck World Health Organization blue book: Editors’ perspectives. Hum. Pathol. 66, 10–12 (2017).
Huang, W. B., Chan, J. Y. W. & Liu, D. L. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China: Human Papillomavirus and NPC. Cancer 124, 530–536 (2018).
Google Scholar
Almangush, A. et al. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: A multicenter study. Hum. Pathol. 81, 211–219 (2018).
Google Scholar
Ruuskanen, M. et al. Outcome of nasopharyngeal carcinoma in Finland: A nationwide study. Acta Oncol. 57, 251–256 (2018).
Google Scholar
Guo, R. et al. The evolution of nasopharyngeal carcinoma staging. BJR 92, 20190244 (2019).
Google Scholar
Ferlay, J. et al. Global Cancer Observatory: Cancer Today (2018). (2020).
Lee, A. W. M. et al. The battle against nasopharyngeal cancer. Radiother. Oncol. 104, 272–278 (2012).
Google Scholar
Kernohan, M. D., Clark, J. R., Gao, K., Ebrahimi, A. & Milross, C. G. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch. Otolaryngol. Head Neck Surg. 136, 1235 (2010).
Google Scholar
Zhu, Y., Song, X., Li, R., Quan, H. & Yan, L. Assessment of nasopharyngeal cancer in young patients aged ≤ 30 years. Front. Oncol. 9, (2019).
Lee, A. W. M. et al. The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral Oncol. 48, 1007–1013 (2012).
Lin, J.-C. et al. Quantification of plasma Epstein–Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N. Engl. J. Med. 350, 2461–2470 (2004).
Google Scholar
Wang, W.-Y. et al. Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein–Barr virus DNA levels. Cancer 119, 963–970 (2013).
Google Scholar
Le, Q.-T. et al. An international collaboration to harmonize the quantitative plasma Epstein–Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma. Clin. Cancer Res. 19, 2208–2215 (2013).
Google Scholar
Pan, X.-X. et al. A simplified T classification based on the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma. CMAR 11, 3163–3169 (2019).
Akcay, M., Etiz, D., Celik, O. & Ozen, A. Evaluation of prognosis in nasopharyngeal cancer using machine learning. Technol. Cancer Res. Treat. 19, 153303382090982 (2020).
Google Scholar
Alabi, R. O., Elmusrati, M., Leivo, I., Almangush, A. & Mäkitie, A. A. Advanced-stage tongue squamous cell carcinoma: A machine learning model for risk stratification and treatment planning. Acta Oto-Laryngol. (2023) https://doi.org/10.1080/00016489.2023.2172208.
Oei, R. W. et al. Progression-free survival prediction in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: Machine learning vs traditional statistics. J. Personal. Med. 11, 787 (2021).
Google Scholar
Chen, T. et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am. J. Kidney Dis. 74, 300–309 (2019).
Google Scholar
Li, Y. et al. Nomograms to estimate long-term overall survival and tongue cancer-specific survival of patients with tongue squamous cell carcinoma. Cancer Med. 6, 1002–1013 (2017).
Google Scholar
SEER, Program. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data 1973–2009, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission (2012).
Ramspek, C. L., Jager, K. J., Dekker, F. W., Zoccali, C. & van Diepen, M. External validation of prognostic models: What, why, how, when and where?. Clin. Kidney J. 14, 49–58 (2021).
Google Scholar
Omobolaji Alabi, R. et al. Application of artificial intelligence for overall survival risk stratification in oropharyngeal carcinoma: A validation of ProgTOOL. Int. J. Med. Inform. 175, 105064 (2023).
Google Scholar
Ribeiro, M. T., Singh, S. & Guestrin, C. ‘Why Should i trust you?’: Explaining the predictions of any classifier. arXiv:1602.04938 [cs, stat] (2016).
Gramegna, A. & Giudici, P. SHAP and LIME: An Evaluation of discriminative power in credit risk. Front. Artif. Intell. 4, 752558 (2021).
Google Scholar
Alabi, R., Almangush, A., Elmusrati, M., Leivo, I. & Mäkitie, A. A. An interpretable machine learning prognostic system for risk stratification in oropharyngeal cancer. Int. J. Med. Inform. 168, 104896 (2022).
Google Scholar
Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. In 31st Conference on Neural Information Processing Systems (NIPS 2017), Long Beach, CA, USA. (2017).
Joseph, A. Parametric inference with universal function approximators. (2019) https://doi.org/10.48550/ARXIV.1903.04209.
Alabi, R. O. et al. Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer. Int. J. Med. Inform. https://doi.org/10.1016/j.ijmedinf.2019.104068 (2019).
Google Scholar
Alabi, R. O. et al. Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: A Web-based prognostic tool. Virchows Arch. 475, 489–497 (2019).
Google Scholar
Bur, A. M. et al. Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral Oncol. 92, 20–25 (2019).
Google Scholar
Karadaghy, O. A., Shew, M., New, J. & Bur, A. M. Development and assessment of a machine learning model to help predict survival among patients with oral squamous cell carcinoma. JAMA Otolaryngol. Head Neck Surg. 145, 1115 (2019).
Google Scholar
Karadaghy, O. A., Kallogjeri, D. & Piccirillo, J. F. Development of a new clinical severity staging system for patients with nonmetastatic papillary thyroid carcinoma. JAMA Otolaryngol. Head Neck Surg. 143, 1173 (2017).
Google Scholar
Chen, T. & Guestrin, C. XGBoost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785–794 (ACM, 2016). https://doi.org/10.1145/2939672.2939785.
Chen, X. et al. An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features. Oral Oncol. 118, 105335 (2021).
Google Scholar
Hamilton, S. N. et al. Asian versus Non-Asian outcomes in nasopharyngeal carcinoma: A North American population-based analysis. Am. J. Clin. Oncol. 39, 575–580 (2016).
Google Scholar
Li, W.-Z. et al. Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival. Biol. Sex Differ. 12, 18 (2021).
Google Scholar
Qiu, W.-Z. et al. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 143, 1563–1572 (2017).
Google Scholar
Li, Y. et al. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: A case–control study. BMC Cancer 17, 567 (2017).
Google Scholar
Wei, K. et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin. J. Cancer. 33, 381–387 (2014).
Google Scholar
Cao, S.-M., Simons, M. J. & Qian, C.-N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin. J. Cancer 30, 114–119 (2011).
Google Scholar
Yeung, D. C. M., Yeung, Z., Wong, E. W. Y., Vlantis, A. C. & Chan, J. Y. K. Neck lymph node status on survival of regionally recurrent or persistent nasopharyngeal carcinoma. Sci. Rep. 10, (2020).
Luo, J. et al. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973–1997. Eur. J. Epidemiol. 22, 513–521 (2007).
Google Scholar
Yeh, S.-A., Tang, Y., Lui, C.-C. & Huang, E.-Y. Treatment outcomes of patients with AJCC Stage IVC nasopharyngeal carcinoma: Benefits of primary radiotherapy. Jpn. J. Clin. Oncol. 36, 132–136 (2006).
Google Scholar
Lin, S. et al. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer. Am. J. Clin. Oncol. 35, 474–479 (2012).
Google Scholar
Chen, M.-Y. et al. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. Chin. J. Cancer 32, 604–613 (2013).
Google Scholar
Chua, D. T. T., Sham, J. S. T., Wei, W. I., Ho, W.-K. & Au, G. K. H. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer 92, 2845–2855 (2001).
Google Scholar
Lin, S. et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: Report on the 3-year outcome of a prospective series. Int. J. Radiat. Oncol. Biol. Phys. 75, 1071–1078 (2009).
Google Scholar
Sun, J., Huang, Z., Hu, Z. & Sun, R. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: A retrospective observational study based on SEER database. J. Transl. Med. 15, 116 (2017).
Google Scholar
Zhu, Q. et al. Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma. Tumor Biol. 37, 3349–3357 (2016).
Google Scholar
Razak, A. R. A. et al. Nasopharyngeal carcinoma: The next challenges. Eur. J. Cancer 46, 1967–1978 (2010).
Google Scholar
Tian, Y. et al. Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis. Sci. Rep. 9, (2019).
Teo, P. M. L., Kwan, W. H., Lee, W. Y., Leung, S. F. & Johnson, P. J. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77, 2423–2431 (1996).
Google Scholar
Ong, Y. K. et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur. J. Cancer 39, 1535–1541 (2003).
Google Scholar
Fandi, A. et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J. Clin. Oncol. 18, 1324–1330 (2000).
Google Scholar
Khanfir, A., Frikha, M., Ghorbel, A., Drira, M. M. & Daoud, J. Prognostic factors in metastatic nasopharyngeal carcinoma. Cancer/Radiothérapie 11, 461–464 (2007).
Google Scholar
Jin, Y. et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area. Eur. J. Cancer 48, 882–888 (2012).
Google Scholar
Pan, C.-C. et al. Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp. Ther. Med. 4, 334–338 (2012).
Google Scholar
AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. (Springer, 2010).
Setton, J., Wolden, S., Caria, N. & Lee, N. Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature. Head Neck 34, 753–757 (2012).
Google Scholar
Hu, S. et al. Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis. Med. Oncol. 32, 224 (2015).
Google Scholar
Qiu, W.-Z. et al. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: A retrospective controlled study. Chin. J. Cancer 35, (2016).
Sun, X.-S. et al. The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: A cohort study from 1990 to 2012. Int. J. Radiat. Oncol. Biol. Phys. 105, 581–590 (2019).
Google Scholar
Peng, G. et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother. Oncol. 104, 286–293 (2012).
Google Scholar
Hui, E. P. et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. JCO 27, 242–249 (2009).
Google Scholar
Du, T., Xiao, J., Qiu, Z. & Wu, K. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. PLoS ONE 14, e0219611 (2019).
Google Scholar
